Bio Pharma Dive
NOVEMBER 21, 2024
The startup, Pep2Tango, is combining four methods of accelerating weight loss into one medicine in the hopes of developing a treatment that can improve upon drugs like Wegovy and Zepbound.
Rethinking Clinical Trials
NOVEMBER 21, 2024
In a new commentary, members of the NIH Pragmatic Trials Collaboratory’s Ethics and Regulatory Core explore the potential of pragmatic trials to improve demographic representativeness and health equity in clinical research. The article, “Untapped Potential? Representativeness in Pragmatic Clinical Trials,” was published online ahead of print in JAMA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 21, 2024
Venture capital firms incubate, grow and finance dozens of new drug companies each year. Follow the money they channel into the industry with this database.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 21, 2024
Mouse cortical neurons. (ALol88/Wikimedia Commons/CC by 4.0) Our brain isn’t the only place memories form in our body. New York University (NYU) researchers have discovered learning through repetition may be fundamental to all of our cells. The process may also help explain why taking breaks is such a powerful learning tool.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
NOVEMBER 21, 2024
Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML
Bio Pharma Dive
NOVEMBER 21, 2024
Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to overcome the looming loss of exclusivity for some of its top-selling medicines.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
NOVEMBER 21, 2024
In buying Westlake-backed Kate Therapeutics, Novartis gets a handful of preclinical gene therapies targeting diseases like Duchenne muscular dystrophy and myotonic dystrophy type 1.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 21, 2024
Critical infrastructure in biopharma and medical devices plays a vital role in enabling innovation, bolstering research and development, and ensuring the production of novel drugs and products. It ensures scalability, quality control, and regulatory compliance.
Pharmaceutical Technology
NOVEMBER 21, 2024
Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.
XTalks
NOVEMBER 21, 2024
Eli Lilly shared new data last week from a study, which highlights the long-term efficacy of tirzepatide in preventing diabetes progression among prediabetic patients. Results from the Phase III SURMOUNT-1 three-year study (176-week treatment period) showed that nearly 99 percent of participants remained diabetes-free over three years. SURMOUNT is the longest completed study to date of tirzepatide.
Pharmaceutical Technology
NOVEMBER 21, 2024
The EC has granted marketing authorisation for Pfizer's anti-tissue factor pathway inhibitor (anti-TFPI), HYMPAVZI to treat haemophilia.
Fierce Pharma
NOVEMBER 21, 2024
As he introduced Novartis’ meet-the-management event Thursday in London, CEO Vas Narasimhan hammered home Novartis’ status as a streamlined, “pure-play, innovative medicines” company and the succes | Novartis has adjusted its compound annual growth rate expectation from 5%-plus to 6%-plus through 2029. The Swiss company cited the momentum of its current growth drivers, which have paved the way for a strong sales performance this year.
Pharmaceutical Technology
NOVEMBER 21, 2024
Events like the RFK Jr nomination as US HHS head, Labour’s 10-year plan, and centralised EU funding will steer the sector’s future.
pharmaphorum
NOVEMBER 21, 2024
Discover how Within3's community-driven platform helps businesses gather and utilise data effectively. Explore our solution spotlight for insights into their innovative approach.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
NOVEMBER 21, 2024
Technology has changed the clinical trial landscape forever, with application programming interfaces (APIs) growing in importance.
XTalks
NOVEMBER 21, 2024
The US Food and Drug Administration (FDA) has granted Breakthrough Device clearance to Ultromics’ EchoGo Amyloidosis device through its Total Product Lifecycle Advisory Program (TAP). Cardiac amyloidosis, a serious and often underdiagnosed heart condition, poses significant diagnostic challenges even for experienced clinicians. It is characterized by the build-up of abnormal protein deposits in the heart tissue, leading to stiffening of the heart walls and impairing its ability to pump blood eff
Pharmaceutical Technology
NOVEMBER 21, 2024
The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell platforms.
Medical Xpress
NOVEMBER 21, 2024
A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and introduces a new approach that paves the way for more personalized treatment strategies for patients with this deadly brain tumor.
Pharmaceutical Technology
NOVEMBER 21, 2024
RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.
pharmaphorum
NOVEMBER 21, 2024
Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
Pharmaceutical Technology
NOVEMBER 21, 2024
The South Korean CDMO has now partnered with 17 of the world’s top 20 pharma companies, as per the company.
XTalks
NOVEMBER 21, 2024
Traditional syphilis testing often requires clinic or lab visits, posing challenges for individuals seeking privacy or with limited healthcare access. NOWDiagnostics’ First To Know Syphilis Test circumvents these barriers with a convenient, in-home solution offering results in just 15 minutes. The test, the first of its kind approved for over-the-counter (OTC) use in the US, detects antibodies for Treponema pallidum , the bacterium responsible for syphilis.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Medical Xpress
NOVEMBER 21, 2024
Life expectancy in the U.S. varies by more than 20 years depending on an individual's race and ethnicity and where they live. These widespread and persistent life expectancy disparities have divided the country into "ten Americas," according to new research examining inequities in US life expectancy between 2000 and 2021, published in The Lancet.
pharmaphorum
NOVEMBER 21, 2024
Shares in genetic testing company 23andMe continue to slide after prominent investors announce plans to sell their stakes.
Medical Xpress
NOVEMBER 21, 2024
New research by a team at Georgia State University is uncovering surprising insights about brain pathways that could offer alternative ways for practitioners to identify early signs of schizophrenia. The research is published in the journal Nature Mental Health.
pharmaphorum
NOVEMBER 21, 2024
Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Medical Xpress
NOVEMBER 21, 2024
Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP inhibitor drug olaparib, according to new research published in the journal Cancer Cell.
Fierce Pharma
NOVEMBER 21, 2024
Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of Roche's Vabysmo on Asian patients with polypoidal choroidal vasculopathy suggest that the injected treatment is effective. After 16 weeks, patients showed vision improvement which was equivalent to reading roughly one and a half more lines on an eye chart.
Drug Patent Watch
NOVEMBER 21, 2024
In the complex world of biopharmaceuticals, setting the right price for a new medicine is both an art and a science. It’s a decision that can make or break a product’s success, impacting everything from patient access to long-term profitability. Let’s dive into the intricacies of this crucial process and explore how companies can navigate the challenging waters of medicine launch pricing.
Medical Xpress
NOVEMBER 21, 2024
Shorter days and lack of sunlight can greatly affect one's mental state. People often suffer from seasonal affective disorder (SAD) during the fall and winter months due to lack of sunlight. A Baylor College of Medicine psychiatrist explains how to cope during this time.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
187 
Let's personalize your content